• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环丙沙星/金属阳离子复合物用于肺部给药的体外生物药剂学评价

In vitro biopharmaceutical evaluation of ciprofloxacin/metal cation complexes for pulmonary administration.

作者信息

Brillault J, Tewes F, Couet W, Olivier J C

机构信息

Inserm U1070, Pôle Biologie Santé, 1 Rue Georges Bonnet, Poitiers, France; Université de Poitiers, UFR de Médecine et Pharmacie, 15 Rue de l'Hôtel Dieu, Poitiers, France.

Inserm U1070, Pôle Biologie Santé, 1 Rue Georges Bonnet, Poitiers, France; Université de Poitiers, UFR de Médecine et Pharmacie, 15 Rue de l'Hôtel Dieu, Poitiers, France; CHU de Poitiers, Service de Toxicologie-Pharmacocinétique, 2 rue de la Milétrie, Poitiers, France.

出版信息

Eur J Pharm Sci. 2017 Jan 15;97:92-98. doi: 10.1016/j.ejps.2016.11.011. Epub 2016 Nov 15.

DOI:10.1016/j.ejps.2016.11.011
PMID:27863308
Abstract

Pulmonary delivery of fluoroquinolones (FQs) is an interesting approach to treat lung infections as it may lead to high local concentrations while minimizing systemic exposure. However, FQs have a rapid diffusion through the lung epithelium giving the pulmonary route no advantage compared to the oral route. Interactions between FQs and metal cations form complexes which limit the diffusion through the epithelial barrier and would reduce the absorption of FQs and maintain high concentrations in the lung. The effects of this complexation depend on the FQ and the metal cations and optimum partners should be selected through in vitro experiments prior to aerosol drug formulation. In this study, CIP was chosen as a representative FQ and 5 cations (Ca, Mg, Zn, Al, Cu) were selected to study the complexation and its effects on permeability, antimicrobial efficacy and cell toxicity. The results showed that the apparent association constants between CIP and cations ranked with the descending order: Cu>Al>Zn>Mg>Ca. When a target of 80% complexation was reached with the adequate concentrations of cations, the CIP permeability through the Calu-3 lung epithelial cells was decreased of 50%. Toxicity of the CIP on the Calu-3 cells, with an EC50 evaluated at 7μM, was not significantly affected by the presence of the cations. The minimum inhibitory concentration of CIP for Pseudomonas aeruginosa was not affected or slightly increased in the range of cation concentrations tested, except for Mg. In conclusion, permeability was the main parameter that was affected by the metal cation complexation while cell toxicity and antimicrobial activity were not or slightly modified. Cu, with the highest apparent constant of association and with no effect on cell toxicity and antimicrobial activity of the CIP, appeared as a promising cation for the development of a controlled-permeability formulation of CIP for lung treatment.

摘要

氟喹诺酮类药物(FQs)的肺部给药是治疗肺部感染的一种有趣方法,因为它可能导致高局部浓度,同时将全身暴露降至最低。然而,FQs可快速穿过肺上皮细胞,与口服途径相比,肺部给药途径并无优势。FQs与金属阳离子之间的相互作用形成复合物,限制了其通过上皮屏障的扩散,会减少FQs的吸收并在肺部维持高浓度。这种络合作用的效果取决于FQs和金属阳离子,在进行气雾剂药物制剂之前,应通过体外实验选择最佳的配对组合。在本研究中,选择环丙沙星(CIP)作为代表性的FQs,并选择5种阳离子(钙、镁、锌、铝、铜)来研究络合作用及其对通透性、抗菌效果和细胞毒性的影响。结果表明,CIP与阳离子之间的表观缔合常数按降序排列为:铜>铝>锌>镁>钙。当用适当浓度的阳离子达到80%的络合目标时,CIP通过Calu-3肺上皮细胞的通透性降低了50%。阳离子的存在对CIP对Calu-3细胞的毒性(EC50评估为7μM)没有显著影响。除镁外,在所测试的阳离子浓度范围内,CIP对铜绿假单胞菌的最低抑菌浓度未受影响或略有增加。总之,通透性是受金属阳离子络合作用影响的主要参数,而细胞毒性和抗菌活性未受影响或略有改变。铜具有最高的表观缔合常数,且对CIP的细胞毒性和抗菌活性没有影响,似乎是开发用于肺部治疗的CIP控释制剂的一种有前景的阳离子。

相似文献

1
In vitro biopharmaceutical evaluation of ciprofloxacin/metal cation complexes for pulmonary administration.环丙沙星/金属阳离子复合物用于肺部给药的体外生物药剂学评价
Eur J Pharm Sci. 2017 Jan 15;97:92-98. doi: 10.1016/j.ejps.2016.11.011. Epub 2016 Nov 15.
2
Efficacy of Ciprofloxacin and Its Copper Complex against Pseudomonas aeruginosa Biofilms.环丙沙星及其铜配合物对铜绿假单胞菌生物膜的疗效。
AAPS PharmSciTech. 2019 May 29;20(5):205. doi: 10.1208/s12249-019-1417-9.
3
Ciprofloxacin-Loaded Inorganic-Organic Composite Microparticles To Treat Bacterial Lung Infection.载有环丙沙星的无机-有机复合微粒用于治疗细菌性肺部感染。
Mol Pharm. 2016 Jan 4;13(1):100-12. doi: 10.1021/acs.molpharmaceut.5b00543. Epub 2015 Dec 19.
4
New aerosol formulation to control ciprofloxacin pulmonary concentration.新型气雾剂配方控制环丙沙星肺部浓度。
J Control Release. 2018 Feb 10;271:118-126. doi: 10.1016/j.jconrel.2017.12.021. Epub 2017 Dec 22.
5
Ciprofloxacin-metal complexes -stability and toxicity tests in the presence of humic substances.环丙沙星-金属配合物在腐殖质存在下的稳定性和毒性测试。
Chemosphere. 2018 Jul;202:549-559. doi: 10.1016/j.chemosphere.2018.03.117. Epub 2018 Mar 20.
6
Effects of Cu and Ca cations and Fe/Al coating on ciprofloxacin sorption onto sand media.铜和钙阳离子及铁/铝涂层对砂介质吸附环丙沙星的影响。
J Hazard Mater. 2013 May 15;252-253:375-81. doi: 10.1016/j.jhazmat.2013.03.014. Epub 2013 Mar 15.
7
In vivo efficacy of a dry powder formulation of ciprofloxacin-copper complex in a chronic lung infection model of bioluminescent Pseudomonas aeruginosa.在生物发光铜绿假单胞菌慢性肺部感染模型中,环丙沙星-铜复合物干粉制剂的体内疗效。
Eur J Pharm Biopharm. 2020 Jul;152:210-217. doi: 10.1016/j.ejpb.2020.05.014. Epub 2020 May 20.
8
A novel gel based on an ionic complex from a dendronized polymer and ciprofloxacin: Evaluation of its use for controlled topical drug release.一种基于树枝状聚合物和环丙沙星的离子配合物的新型凝胶:评估其用于控制局部药物释放的用途。
Mater Sci Eng C Mater Biol Appl. 2016 Dec 1;69:236-46. doi: 10.1016/j.msec.2016.06.071. Epub 2016 Jun 23.
9
A new therapeutic avenue for bronchiectasis: Dry powder inhaler of ciprofloxacin nanoplex exhibits superior ex vivo mucus permeability and antibacterial efficacy to its native ciprofloxacin counterpart.支气管扩张症的新治疗途径:环丙沙星纳米复合物干粉吸入剂在体外黏液通透性和抗菌效果方面优于其天然环丙沙星对应物。
Int J Pharm. 2018 Aug 25;547(1-2):368-376. doi: 10.1016/j.ijpharm.2018.06.017. Epub 2018 Jun 7.
10
Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 1. Ciprofloxacin, moxifloxacin, and grepafloxacin.大鼠雾化抗菌剂的生物制药特性:1. 环丙沙星、莫西沙星和格帕沙星。
Antimicrob Agents Chemother. 2014 Jul;58(7):3942-9. doi: 10.1128/AAC.02818-14. Epub 2014 May 5.

引用本文的文献

1
PK-PD Evaluation of Inhaled Microparticles loaded with Ciprofloxacin-Copper complex in a Rat Model of Chronic Lung Infection.环丙沙星-铜复合物负载吸入性微粒在大鼠慢性肺部感染模型中的药代动力学-药效学评价
Int J Pharm X. 2023 Mar 11;5:100178. doi: 10.1016/j.ijpx.2023.100178. eCollection 2023 Dec.
2
Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines.延长吸入药物肺部暴露的药物策略。
Acta Pharm Sin B. 2021 Aug;11(8):2565-2584. doi: 10.1016/j.apsb.2021.05.015. Epub 2021 May 21.
3
Characterization of Ciprofloxacin-Bismuth-Loaded Antibacterial Wound Dressing.
载有环丙沙星-铋的抗菌创伤敷贴的特性。
Molecules. 2020 Nov 3;25(21):5096. doi: 10.3390/molecules25215096.
4
Optimization of inhalable liposomal powder formulations and evaluation of their in vitro drug delivery behavior in Calu-3 human lung epithelial cells.优化吸入性脂质体粉末制剂,并评估其在 Calu-3 人肺上皮细胞中的体外药物传递行为。
Int J Pharm. 2020 Aug 30;586:119570. doi: 10.1016/j.ijpharm.2020.119570. Epub 2020 Jun 25.
5
Control of the Lung Residence Time of Highly Permeable Molecules after Nebulization: Example of the Fluoroquinolones.雾化后高渗透性分子在肺部停留时间的控制:以氟喹诺酮类药物为例。
Pharmaceutics. 2020 Apr 23;12(4):387. doi: 10.3390/pharmaceutics12040387.
6
Inhalable liposomal powder formulations for co-delivery of synergistic ciprofloxacin and colistin against multi-drug resistant gram-negative lung infections.可吸入脂质体粉末制剂用于协同递送达托霉素和黏菌素治疗多重耐药革兰氏阴性肺部感染
Int J Pharm. 2020 Feb 15;575:118915. doi: 10.1016/j.ijpharm.2019.118915. Epub 2019 Dec 6.
7
Evaluation of co-delivery of colistin and ciprofloxacin in liposomes using an in vitro human lung epithelial cell model.采用体外人肺上皮细胞模型评价多黏菌素和环丙沙星脂质体共递送
Int J Pharm. 2019 Oct 5;569:118616. doi: 10.1016/j.ijpharm.2019.118616. Epub 2019 Aug 12.